Transglutaminase and EFSA: What does the assessment mean for food applications?

Transglutaminase is used in many food applications—at the same time, EFSA’s regulatory assessment is becoming increasingly important.

Many manufacturers and product developers are currently asking:

Which transglutaminase is secured with regard to the upcoming EU positive list?

EFSA assessment of transglutaminase

As part of the European authorisation procedure for food enzymes, enzymes are comprehensively assessed scientifically.

A current EFSA assessment is available for transglutaminase from Streptomyces mobaraensis.

The result:

EFSA concludes that this enzyme does not raise safety concerns under the intended conditions of use.

What does this mean in practical terms for its use?

The EFSA assessment is a key step in the process of inclusion in the EU positive list in accordance with Regulation (EC) No 1332/2008.

This means:

Enzymes that have successfully completed this assessment procedure provide a clear regulatory basis for use in the EU market.

Classification for NewBind Transglutaminase

In our NewBind Transglutaminase blends, we use a raw enzyme that has already been assessed as part of the EFSA procedure.

This means NewBind is based on a transglutaminase for which a well-founded safety assessment by EFSA is available.

The processing and formulation of our blends then takes place in Germany under controlled conditions.

Why is this relevant for users?

There are currently various transglutaminase products on the market—not all are based on enzymes with a comparable regulatory status.

For food manufacturers, this means:

  • A better regulatory starting point when using an assessed enzyme
  • Support with audits and documentation
  • Greater planning certainty with regard to future EU requirements
  • Reduced risk when selecting suppliers

NewBind – transglutaminase blends from Germany

Our NewBind systems are developed and produced in Germany.

We combine:

  • An enzyme that has already been assessed
  • Application-optimised formulations
  • Technical support for our customers

Conclusion

The EFSA assessment of transglutaminase is a decisive factor for future use in the EU.

With NewBind, you are choosing a solution based on an enzyme that has already been assessed, providing a solid foundation for current and future requirements.